Related references
Note: Only part of the references are listed.Thrombosis in primary myelofibrosis: incidence and risk factors
Tiziano Barbui et al.
BLOOD (2010)
Portal vein thrombosis, revisited
Massimo Primignani
DIGESTIVE AND LIVER DISEASE (2010)
Acute Portal Vein Thrombosis Unrelated to Cirrhosis: A Prospective Multicenter Follow-up Study
Aurelie Plessier et al.
HEPATOLOGY (2010)
The 2008 revision of the World Health Organization (WHO) classification of myeloid neoplasms and acute leukemia: rationale and important changes
James W. Vardiman et al.
BLOOD (2009)
The impact of JAK2 and MPL mutations on diagnosis and prognosis of splanchnic vein thrombosis: a report on 241 cases
Jean-Jacques Kiladjian et al.
BLOOD (2008)
Portal Hypertension-Related Complications After Acute Portal Vein Thrombosis: Impact of Early Anticoagulation
Juan Turnes et al.
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2008)
Recurrent thrombosis in patients with polycythemia vera and essential thrombocythemia: incidence, risk factors, and effect of treatments
Valerio De Stefano et al.
HAEMATOLOGICA (2008)
Classification and diagnosis of myeloproliferative neoplasms: The 2008 World Health Organization criteria and point-of-care diagnostic algorithms
A. Tefferi et al.
LEUKEMIA (2008)
Prognostic factors in noncirrhotic patients with splanchnic vein thromboses
Lucio Amitrano et al.
AMERICAN JOURNAL OF GASTROENTEROLOGY (2007)
Portal vein thrombosis; risk factors, clinical presentation and treatment
Kirstine K. Sogaard et al.
BMC GASTROENTEROLOGY (2007)
The JAK2 V617F mutation frequently occurs in patients with portal and mesenteric venous thrombosis
D. Colaizzo et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2007)
Role of the JAK2 mutation in the diagnosis of chronic myeloproliferative disorders in splanchnic vein thrombosis
Massimo Primignani et al.
HEPATOLOGY (2006)
Evolving consensus in portal hypertension - Report of the Baveno IV Consensus Workshop on methodology of diagnosis and therapy in portal hypertension
R de Franchis
JOURNAL OF HEPATOLOGY (2005)
A gain-of-function mutation of JAK2 in myeloproliferative disorders
R Kralovics et al.
NEW ENGLAND JOURNAL OF MEDICINE (2005)
Vascular and neoplastic risk in a large cohort of patients with polycythemia vera
R Marchioli et al.
JOURNAL OF CLINICAL ONCOLOGY (2005)
Risk factors for thrombophilia in extrahepatic portal vein obstruction
M Primignani et al.
HEPATOLOGY (2005)
Efficacy and safety of low-dose aspirin in polycythemia vera
R Landolfi et al.
NEW ENGLAND JOURNAL OF MEDICINE (2004)
Factor V Leiden mutation carriership and venous thromboembolism in Polycythemia Vera and Essential Thrombocythemia
M Ruggeri et al.
AMERICAN JOURNAL OF HEMATOLOGY (2002)
Portal or hepatic vein thrombosis as the first presentation of a myeloproliferative disorder in patients with normal peripheral blood counts
C McNamara et al.
CLINICAL AND LABORATORY HAEMATOLOGY (2002)
Extrahepatic portal vein thrombosis: aetiology and determinants of survival
HLA Janssen et al.
GUT (2001)
Current outcome of portal vein thrombosis in adults: Risk and benefit of anticoagulant therapy
B Condat et al.
GASTROENTEROLOGY (2001)
Recent portal or mesenteric venous thrombosis: Increased recognition and frequent recanalization on anticoagulant therapy
B Condat et al.
HEPATOLOGY (2000)
Incidence, clinical features and outcome of essential thrombocythaemia in a well defined geographical area
MK Jensen et al.
EUROPEAN JOURNAL OF HAEMATOLOGY (2000)
Share Paper
